Literature DB >> 15067505

[How neuropathic is sciatica? The mixed pain concept].

R Baron1, A Binder.   

Abstract

Different pathophysiological mechanisms are thought to operate in chronic sciatica. Nociceptive and neuropathic pain components can be distinguished. Neuropathic pain may be caused by lesions of nociceptive sprouts within the degenerated disc (local neuropathic), mechanical compression of the nerve root (mechanical neuropathic root pain), or by action of inflammatory mediators (inflammatory neuropathic root pain) originating from the degenerative disc even without any mechanical compression. Since different pain-generating mechanisms possibly underlie sciatic pain, the term mixed pain syndrome was established. The incidence of each pain component in chronic sciatica as well as validated diagnostic tools to identify them remain unknown. Current analgesic therapeutic first-line strategies for chronic sciatica rely on NSAIDs that are known to relieve nociceptive pain only. In neuropathic pain, different therapeutic approaches are effective, i.e., antidepressants such as amitriptyline and anticonvulsants such as gabapentin, carbamazepine, and pregabalin. Therefore, the combination of these analgesic compounds with NSAID could be useful in patients with sciatic pain who do not respond to NSAID.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067505     DOI: 10.1007/s00132-004-0645-0

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  17 in total

1.  Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury.

Authors:  Y C Tsai; S J Won
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

2.  Nerve ingrowth into diseased intervertebral disc in chronic back pain.

Authors:  A J Freemont; T E Peacock; P Goupille; J A Hoyland; J O'Brien; M I Jayson
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

3.  Cytokine production and treatment response in major depressive disorder.

Authors:  S Lanquillon; J C Krieg; U Bening-Abu-Shach; H Vedder
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

4.  Inflammatory cytokines in the herniated disc of the lumbar spine.

Authors:  H Takahashi; T Suguro; Y Okazima; M Motegi; Y Okada; T Kakiuchi
Journal:  Spine (Phila Pa 1976)       Date:  1996-01-15       Impact factor: 3.468

5.  Cerebrospinal fluid protein concentrations related to clinical findings in patients with sciatica caused by disk herniation.

Authors:  J S Skouen; J L Larsen; S E Vollset
Journal:  J Spinal Disord       Date:  1994-02

6.  Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2.

Authors:  J D Kang; H I Georgescu; L McIntyre-Larkin; M Stefanovic-Racic; W F Donaldson; C H Evans
Journal:  Spine (Phila Pa 1976)       Date:  1996-02-01       Impact factor: 3.468

7.  [Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].

Authors:  S Mense
Journal:  Schmerz       Date:  2001-12       Impact factor: 1.107

Review 8.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

Review 9.  [Neuropathic pain. The long path from mechanisms to mechanism-based treatment].

Authors:  R Baron
Journal:  Anaesthesist       Date:  2000-05       Impact factor: 1.041

Review 10.  Postherpetic neuralgia: irritable nociceptors and deafferentation.

Authors:  H L Fields; M Rowbotham; R Baron
Journal:  Neurobiol Dis       Date:  1998-10       Impact factor: 5.996

View more
  26 in total

1.  Psychological defensive profile of sciatica patients with neuropathic pain and its relationship to quality of life.

Authors:  A Tutoglu; A Boyaci; I F Karababa; I Koca; E Kaya; A Kucuk; A Yetisgin
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

2.  Intradermal capsaicin as a neuropathic pain model in patients with unilateral sciatica.

Authors:  Verna Aykanat; Melanie Gentgall; Nancy Briggs; Desmond Williams; Sharon Yap; Paul Rolan
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

Review 3.  [Obesity and low back pain--biology, biomechanics and epidemiology].

Authors:  C H Flamme
Journal:  Orthopade       Date:  2005-07       Impact factor: 1.087

4.  Limaprost alfadex and nonsteroidal anti-inflammatory drugs for sciatica due to lumbar spinal stenosis.

Authors:  Akira Onda; Shin-Ichi Kikuchi; Shoji Yabuki; Koji Otani; Takuya Nikaido; Kazuyuki Watanabe; Shin-Ichi Konno
Journal:  Eur Spine J       Date:  2012-10-23       Impact factor: 3.134

5.  Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions.

Authors:  Kathrin Arning; Ralf Baron
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 6.  The evaluation of neuropathic components in low back pain.

Authors:  Rainer Freynhagen; Ralf Baron
Journal:  Curr Pain Headache Rep       Date:  2009-06

Review 7.  [Symptoms and pathophysiological mechanisms of neuropathic pain syndromes].

Authors:  S Lanz; C Maihöfner
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

Review 8.  How to diagnose neuropathic pain? The contribution from clinical examination, pain questionnaires and diagnostic tests.

Authors:  S La Cesa; S Tamburin; V Tugnoli; G Sandrini; S Paolucci; M Lacerenza; P Marchettini; G Cruccu; A Truini
Journal:  Neurol Sci       Date:  2015-09-26       Impact factor: 3.307

Review 9.  [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].

Authors:  F Petzke; E K Enax-Krumova; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

10.  Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain.

Authors:  Carlo Luca Romanò; Delia Romanò; Cristina Bonora; Giuseppe Mineo
Journal:  J Orthop Traumatol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.